TY  - JOUR

T1  - Cost-effectiveness of combination nonbiologic disease-modifying antirheumatic drug strategies in patients with early rheumatoid arthritis.

JO  - J Rheumatol

PY  - 2011/01/01

AU  - Tosh JC

AU  - Wailoo AJ

AU  - Scott DL

AU  - Deighton CM

ED  - 

DO  - DOI: 10.3899/jrheum.101327

VL  - 38

IS  - 8

SP  - 1593

EP  - 1600

Y2  - 2024/10/19

ER  -